Xencor at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Xencor takes part in 6 sessions at Antibody Engineering 2026 in San Diego. Its program centers on bispecific antibody engineering and on taking drug candidates from discovery to a first clinical trial filing. Its XenLock Fab domains make heavy chains pair with the right light chains in bispecifics that have one arm per target and last longer in the body.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Xencor Pasadena, CA | |
Develops engineered antibodies using its XmAb Fc and bispecific technologies, for cancer and autoimmune diseases. | Talk Sun Dec 13 1:00pm–1:15pm Talk Sun Dec 13 4:15pm–5:00pm Talk Mon Dec 14 8:00am–8:05am Talk Mon Dec 14 10:55am–11:30am Talk Wed Dec 16 8:10am–8:15am Talk Wed Dec 16 9:15am–9:45am XenLock™ Fab domains for controlled heavy-light chain pairing in native-like 1+1 bispecific antibodies with extended half-life Redesigned antibody arms that pair only with their intended partner, used to build two-target antibodies that last longer in blood. Bispecifics & multispecifics |
Instantly find 20 buyers from Xencor
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect, The Antibody Society or Antibody Engineering & Therapeutics. Submit a correction